Dialysis News and Research

Latest Dialysis News and Research

High-dose influenza vaccine associated fewer hospitalizations in dialysis patients

Results from a new study suggest that high-dose influenza vaccine is associated with lower risk for hospitalizations in kidney failure patients on dialysis. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology

24 Oct 2018

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.

22 Oct 2018

Not exercising is worse than smoking, diabetes or heart disease finds study

The study was published in the latest issue of the JAMA Network Open journal. For this the researchers followed up health, exercise and lifestyle data of 122,007 participants over 23 years to reach these conclusions.

21 Oct 2018

New urea sorbent could speed up the development of wearable artificial kidney

There just aren't enough kidney transplants available for the millions of people with renal failure.

19 Oct 2018

Study: Only 59% of young adults undergoing surgery are fluid responsive

Cheetah Medical, a Massachusetts-based leader in non-invasive fluid management devices, today announced study results leveraging Cheetah Medical technology were presented at the American Society of Anesthesiologists ANESTHESIOLOGY 2018 annual meeting in San Francisco, held from October 13-17.

16 Oct 2018

Research reveals new ways to better protect the kidneys from essential imaging tests

Every year millions of people undergo medical tests and procedures, such as coronary angiography, which use intravascular contrast dyes.

12 Oct 2018

Technology-based positive psychology exercises improve quality of life in kidney dialysis patients

Kidney dialysis patients who engage in technology-based positive psychology exercises during their treatments may significantly improve their depressive symptoms and quality of life, a new study found.

11 Oct 2018

Patient advocacy or political ploy? Union, industry square off over dialysis initiative

This year, California dialysis clinics — and their profits — are in a powerful union's crosshairs. On Nov. 6, the Service Employees International Union-United Healthcare Workers West union hopes to deliver a stinging blow with a ballot measure designed to limit clinic profits.

5 Oct 2018

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today updated positive results from its Phase 1/2 clinical study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic targeting glycolate oxidase for the treatment of primary hyperoxaluria type 1.

4 Oct 2018

Experts call for more transparency about joint-venture ownership of dialysis clinics

Penn Medicine experts in nephrology and health policy call for more transparency about joint-venture ownership of dialysis clinics to better understand what impact these arrangements may have on patient referrals and clinical outcomes.

4 Oct 2018

Feds settle huge whistleblower suit over Medicare Advantage fraud

One of the nation's largest dialysis providers will pay $270 million to settle a whistleblower's allegation that it helped Medicare Advantage insurance plans cheat the government for several years.

1 Oct 2018

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

28 Sep 2018

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

AstraZeneca today announced positive results from the Phase III DECLARE-TIMI 58 cardiovascular outcomes trial for FARXIGA, the broadest SGLT-2 inhibitor CVOT conducted to date.

24 Sep 2018

$CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL$

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.

21 Sep 2018

Inequality issues persist even under new U.S. kidney transplant allocation system

The implementation of a new U.S. kidney transplant allocation system did not solve many of the inequities that low-income and minority kidney disease patients face, Drexel University College of Medicine researchers found in a new study published recently in the journal Clinical Transplantation.

18 Sep 2018

FDA approves new treatment for people with hairy cell leukemia

AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US Food and Drug Administration has approved LUMOXITI (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

14 Sep 2018

MAPK pathway mediates normal kidney development, reveals study

The prevalence of kidney diseases is growing rapidly due to an aging population and an increased incidence of diseases like diabetes.

14 Sep 2018

Trying to protect seniors, the most vulnerable, from formidable foe Florence

Perhaps no other population is as vulnerable during a hurricane as frail, older adults, especially those who are homebound or living in nursing homes. With Hurricane Florence predicted to slam the North Carolina coast Friday, health officials are already scrambling to keep older residents safe.

12 Sep 2018

Consuming more caffeine may help reduce risk of death for people with kidney disease

A new study in Nephrology Dialysis Transplantation indicates that consuming more caffeine may help reduce the risk of death for people with chronic kidney disease.

12 Sep 2018

New LSU research aims to prevent kidney failure caused by type 2 diabetes

A National Institutes of Health grant will help LSU Pennington Biomedical Research Center take the next step to better understanding how to prevent the kidney damage and failure caused by type 2 diabetes.

6 Sep 2018

Dialysis News and Research

Latest Dialysis News and Research

High-dose influenza vaccine associated fewer hospitalizations in dialysis patients

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Not exercising is worse than smoking, diabetes or heart disease finds study

New urea sorbent could speed up the development of wearable artificial kidney

Study: Only 59% of young adults undergoing surgery are fluid responsive

Research reveals new ways to better protect the kidneys from essential imaging tests

Technology-based positive psychology exercises improve quality of life in kidney dialysis patients

Patient advocacy or political ploy? Union, industry square off over dialysis initiative

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Experts call for more transparency about joint-venture ownership of dialysis clinics

Feds settle huge whistleblower suit over Medicare Advantage fraud

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

Inequality issues persist even under new U.S. kidney transplant allocation system

FDA approves new treatment for people with hairy cell leukemia

MAPK pathway mediates normal kidney development, reveals study

Trying to protect seniors, the most vulnerable, from formidable foe Florence

Consuming more caffeine may help reduce risk of death for people with kidney disease

New LSU research aims to prevent kidney failure caused by type 2 diabetes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in